StockData
agilon health, inc. logo

agilon health, inc. (AGL) stock

AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$115.20−1.55 (-1.33%)

Close on Nov 17, 2026Market cap $1.93BP/E –Yield –

Earnings

agilon health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$1.52B
+5.6% on a year earlier
Adjusted EPS, Q3 FY2026
$1.97
-$0.27 a year earlier
Latest guidance
Raised
Nov 4, 2026 · 8 items

Quarterly results

Revenue and earnings per share from each of agilon health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close$1.52B+5.6%$1.97–Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026during market hours$1.49B+7.2%–$70.00Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours––––Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026during market hours$1.57B+3.3%-$0.46–Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025during market hours$1.44B-0.7%-$0.27–Release
Q2 FY2025ended Jun 30, 2025Aug 4, 2025during market hours$1.39B-6.1%-$0.25–Release
Q1 FY2025ended Mar 31, 2025May 6, 2025during market hours$1.53B-4.4%––Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025during market hours$1.52B+43.4%––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024during market hours$1.45B+18.9%––Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024during market hours$1.48B+28.7%-$0.07–Release
Q1 FY2024ended Mar 31, 2024May 7, 2024during market hours$1.60B+40.4%$0.01–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

agilon health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total RevenuesGAAPFY2026$5.87B – $5.89B–NewNov 4, 2026
Total RevenuesFY2026$5.41B – $5.58B–NewFeb 25, 2026
Adjusted EBITDAnon-GAAPFY2026$145.00M – $155.00M–NewNov 4, 2026
Adjusted EBITDAnon-GAAPFY2026-$15.00M – $15.00M–NewFeb 25, 2026
ACO Model MembersFY2026108,000 – 112,000–LoweredNov 4, 2026
ACO Model MembersFY2026100,000 – 105,000–LoweredFeb 25, 2026
Avg. Medicare Advantage MembersFY2026451,000 – 453,000–LoweredNov 4, 2026
Avg. Medicare Advantage MembersFY2026427,000 – 437,000–LoweredFeb 25, 2026
Geography Entry CostsFY2026$15.00M–NewNov 4, 2026
Geography Entry CostsFY2026$15.00M–NewFeb 25, 2026
Medical Marginnon-GAAPFY2026$300.00M – $350.00M–NewFeb 25, 2026
Medicare Advantage MembersFY2026445,000 – 450,000–NewNov 4, 2026
Medicare Advantage MembersFY2026425,000 – 435,000–NewFeb 25, 2026
MSERFY202690.3% – 90.5%–NewNov 4, 2026
Selling, general and administrative expensesFY2026$234.00M–RaisedFeb 25, 2026
Total Members Live on PlatformFY2026553,000 – 562,000–RaisedNov 4, 2026
Total Members Live on PlatformFY2026525,000 – 540,000–RaisedFeb 25, 2026

Guidance vs results

The last range agilon health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$5.81B – $5.83B$5.93BΣ4QAbove range
Q2 FY2025Revenue$1.44B – $1.51B$1.39BBelow range
Q1 FY2025Revenue$1.48B – $1.52B$1.53BAbove range
Q3 FY2024Revenue$1.47B – $1.48B$1.45BBelow range
Q2 FY2024Revenue$1.55B – $1.57B$1.48BBelow range
Q1 FY2024Revenue$1.61B – $1.63B$1.60BBelow range
Q4 FY2023Revenue$1.05B – $1.06B$1.06BWithin range
Q3 FY2023Revenue$1.13B – $1.14B$1.22BAbove range
Q2 FY2023Revenue$1.11B – $1.12B$1.15BAbove range
Q1 FY2023Revenue$1.07B – $1.09B$1.14BAbove range
Q3 FY2022Revenue$645.00M – $655.00M$695.00MAbove range
Q2 FY2022Revenue$640.00M – $652.00M$670.00MAbove range

Guidance history

Every forecast agilon health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026Adjusted EBITDAFY2026$145.00M – $155.00MNew
Nov 4, 2026MSERFY202690.3% – 90.5%New
Nov 4, 2026Avg. Medicare Advantage MembersFY2026451,000 – 453,000Lowered
Nov 4, 2026Total Members Live on PlatformFY2026553,000 – 562,000Raised
Nov 4, 2026ACO Model MembersFY2026108,000 – 112,000Lowered
Nov 4, 2026Medicare Advantage MembersFY2026445,000 – 450,000New
Nov 4, 2026Geography Entry CostsFY2026$15.00MNew
Nov 4, 2026Total RevenuesFY2026$5.87B – $5.89BNew
Feb 25, 2026Adjusted EBITDAFY2026-$15.00M – $15.00MNew
Feb 25, 2026Adjusted EBITDAQ1 FY2026$35.00M – $45.00MNew
Feb 25, 2026Total Members Live on PlatformFY2026525,000 – 540,000Raised
Feb 25, 2026Medical MarginQ1 FY2026$115.00M – $130.00MNew
Feb 25, 2026Geography Entry CostsQ1 FY2026$3.00MNew
Feb 25, 2026Medicare Advantage MembersFY2026425,000 – 435,000New
Feb 25, 2026ACO Model MembersFY2026100,000 – 105,000Lowered
Feb 25, 2026Avg. Medicare Advantage MembersFY2026427,000 – 437,000Lowered
Feb 25, 2026Geography Entry CostsFY2026$15.00MNew
Feb 25, 2026Selling, general and administrative expensesFY2026$234.00MRaised
Feb 25, 2026Medical MarginFY2026$300.00M – $350.00MNew
Feb 25, 2026Medicare Advantage MembersQ1 FY2026431,000 – 441,000New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases agilon health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Results
  4. Results
  5. Update
  6. News
  7. Results
  8. Results
  9. Update
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?